Equity Profile

ARGX

argenx SE

Health CareBiotechnology$55.4B

May7Thu

Post-Earnings Recap

ReportedQ1-2026Pre-Market1:00 AM EDT

argenx SE Beats on EPS, Stock Down 2.51%

Metric	Actual	Expected	Surprise
EPS	$5.52	$4.19	+6.94%
Revenue	—	$1.1B	—

management commentary, guidance changes, and full analysis available with Pro.

argenx SE Beats on EPS, Stock Down 2.51%

Key Numbers

Metric	Actual	Expected	Surprise
EPS	$5.52	$4.19	+6.94%
Revenue	—	$1.1B	—

Management Commentary

Tone: Unknown

No transcript is on record for this earnings call, so the analysis is based solely on numerical results.

What It Means

argenx SE reported better-than-expected earnings per share, which is a positive sign for profitability. However, the stock fell by 2.51% despite the EPS beat, likely due to the lack of revenue information and guidance. Investors may be cautious given the uncertainty surrounding future performance.

Company Snapshot

argenx SE is a biotechnology company focused on developing innovative therapies for patients with severe autoimmune diseases and cancer. Operating in the Health Care sector, argenx is recognized for its cutting-edge research and development efforts, which are crucial for advancing treatment options in these challenging medical areas.

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and financial health.

$4.19

Revenue

Revenue figures will provide insight into the company's sales performance and market demand for its products.

$1.1B

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+253.11%

Avg Stock Reaction

+0.79%

Last Quarter Recap

In Q4 2025, argenx reported an EPS of $8.02, significantly exceeding analyst expectations. However, the stock experienced a decline of 5.56% the following day, indicating some market skepticism despite the strong earnings.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts are generally optimistic about argenx's upcoming earnings, expecting solid performance based on past results. The consensus EPS of $4.19 suggests continued growth, but investor sentiment may hinge on how the company addresses future guidance.

Bull Case

If argenx beats EPS expectations and shows strong revenue growth, it could reinforce investor confidence and drive the stock higher, especially given its history of positive surprises.

Bear Case

Conversely, if the company misses earnings expectations or fails to provide reassuring guidance, it could lead to a significant sell-off, particularly given the recent stock price volatility.

Key Metrics to Watch

EPS

$4.19

Earnings per share is a key indicator of the company's profitability and financial health.

Revenue

$1.1B

Revenue figures will provide insight into the company's sales performance and market demand for its products.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will the EPS exceed the consensus estimate of $4.19?

A strong EPS figure could validate the company's growth trajectory and boost investor confidence.

What guidance will management provide for future revenue growth?

Future guidance is critical for understanding the company's outlook and could significantly impact stock performance.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate argenx's ability to outperform due to its strong pipeline and recent successful trials, which could lead to higher-than-expected revenue.

Supporting Evidence

The company's recent track record shows an 88% EPS beat rate, indicating a strong likelihood of exceeding expectations.

Options pricing suggests a significant move, indicating that traders are anticipating volatility that may not align with consensus views.

Key Risk

If revenue comes in below $1B, it could undermine confidence in the company's growth trajectory.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is closely watching EPS and revenue guidance to gauge the company's health and growth potential.

Bull Confirmed If

An EPS of $4.50 or higher would confirm strong operational performance and growth potential.

Bear Confirmed If

An EPS below $3.50 would raise concerns about the company's profitability and future prospects.

Pre-Earnings Positioning

Options Market

Implied Move

±6.41%

Historical Avg

±5.0%

Pricing rich

The options market is pricing in a relatively large move, suggesting that traders expect significant volatility around the earnings announcement.

Options are pricing ±6.3% while ARGX has averaged ±5.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

28.1%

Calls (13K)P/C Ratio: 0.56Puts (2K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If argenx beats expectations, history suggests the stock could rise by around 1.26% on the first trading day post-earnings, confirming positive market sentiment.

In-Line / Cautious

If results are in line with expectations but management is cautious, the stock may experience muted movement as investors weigh future growth prospects.

Miss

If the company misses expectations, history suggests a potential decline of about 0.91%, reflecting market disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or pipeline developments.
2Management's commentary on market demand for existing products.
3Insights into cost management and operational efficiency.
4Future guidance on revenue growth and market expansion.
5Responses to analyst questions regarding competitive pressures.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

May4

GRABReported

Grab Holdings Limited

RecapView

May4

GBDCReported

Company Snapshot

Key Metrics to Watch

EPS

Earnings per share is a key indicator of the company's profitability and financial health.

$4.19

Revenue

Revenue figures will provide insight into the company's sales performance and market demand for its products.

$1.1B

Wall Street expectations, options signals, track record, and call prep available with Pro.

Original Pre-Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+253.11%

Avg Stock Reaction

+0.79%

Last Quarter Recap

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If argenx beats EPS expectations and shows strong revenue growth, it could reinforce investor confidence and drive the stock higher, especially given its history of positive surprises.

Bear Case

Conversely, if the company misses earnings expectations or fails to provide reassuring guidance, it could lead to a significant sell-off, particularly given the recent stock price volatility.

Key Metrics to Watch

EPS

$4.19

Earnings per share is a key indicator of the company's profitability and financial health.

Revenue

$1.1B

Revenue figures will provide insight into the company's sales performance and market demand for its products.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will the EPS exceed the consensus estimate of $4.19?

A strong EPS figure could validate the company's growth trajectory and boost investor confidence.

What guidance will management provide for future revenue growth?

Future guidance is critical for understanding the company's outlook and could significantly impact stock performance.

Edge

What the Street Is Missing

Why consensus could be wrong

The consensus may underestimate argenx's ability to outperform due to its strong pipeline and recent successful trials, which could lead to higher-than-expected revenue.

Supporting Evidence

The company's recent track record shows an 88% EPS beat rate, indicating a strong likelihood of exceeding expectations.

Options pricing suggests a significant move, indicating that traders are anticipating volatility that may not align with consensus views.

Key Risk

If revenue comes in below $1B, it could undermine confidence in the company's growth trajectory.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is closely watching EPS and revenue guidance to gauge the company's health and growth potential.

Bull Confirmed If

An EPS of $4.50 or higher would confirm strong operational performance and growth potential.

Bear Confirmed If

An EPS below $3.50 would raise concerns about the company's profitability and future prospects.

Pre-Earnings Positioning

Options Market

Implied Move

±6.41%

Historical Avg

±5.0%

Pricing rich

The options market is pricing in a relatively large move, suggesting that traders expect significant volatility around the earnings announcement.

Options are pricing ±6.3% while ARGX has averaged ±5.0% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

28.1%

Calls (13K)P/C Ratio: 0.56Puts (2K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If argenx beats expectations, history suggests the stock could rise by around 1.26% on the first trading day post-earnings, confirming positive market sentiment.

In-Line / Cautious

If results are in line with expectations but management is cautious, the stock may experience muted movement as investors weigh future growth prospects.

Miss

If the company misses expectations, history suggests a potential decline of about 0.91%, reflecting market disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches or pipeline developments.
2Management's commentary on market demand for existing products.
3Insights into cost management and operational efficiency.
4Future guidance on revenue growth and market expansion.
5Responses to analyst questions regarding competitive pressures.